SAN FRANCISCO, Oct. 24 – Millennium Pharmaceuticals entered a four-year R&D and volume discount supply agreement with Affymetrix, the companies announced Wednesday.

The deal includes co-development of gene expression array processes and applications for drug discovery and development, including next generation GeneChip technology applications.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.